I am not sure, but the request was pretty much word for word to the last company request from Melanie Farris before the March CR. If it was a partnership announcement why wouldn't she say it.
Very disappointing if it is not a strategic investment, given the reason for the CR in March was to position the company for a near term strategic partnership. If they are proposing to go back to the market, I hope that it is at a significant premium given how much more the company is worth now to 6 months ago. After all, the reason given for the last CR was 'to seek to maximize shareholder value to negotiate a strategic investment or partnership in 6 months. ' At the very least, I hope they get the funds they require from the US where biotech valuations are a little more realistic ( latest analyst report values Invion at 12 cents a share before phase 2 results).
Any CR that's not at a significant premium will not reflect well on managment. However, I remain optimistic.
Ann: Trading Halt, page-10
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $13.63M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.2¢ | $7.612K | 3.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 5729449 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 12383990 | 52 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IVX (ASX) Chart |